Unaudited Standalone Financial Result for Second Quarter and Half Year Ended on 30th September 2025
Awaiting price reaction for this filing.
Gold Coin Health Foods Ltd posted Q2 FY26 revenue from operations of Rs 2.14 lacs, up 37% from Rs 1.56 lacs in Q2 FY25, with H1 FY26 revenue at Rs 4.06 lacs versus Rs 2.92 lacs in H1 FY25 (up ~39%). Despite the revenue uptick, the company slipped back to a Q2 standalone loss after tax of Rs 0.83 lacs (EPS of Rs -0.03), reversing Q1's profit. On a half-year basis, the company turned profitable at Rs 2.66 lacs versus a loss of Rs 10.74 lacs in H1 FY25, though this turnaround is largely propped up by Rs 12.63 lacs of other income booked in Q1. The balance sheet remains weak with negative other equity of Rs -195.65 lacs and total assets shrinking to Rs 161.55 lacs from Rs 219.13 lacs at March-end. Operating cash flow was marginally negative at Rs -0.60 lacs for H1 FY26. Importantly, the NCLT approved the company's share capital reduction scheme on October 31, 2025, aimed at wiping out the accumulated losses.
Revenue growth is encouraging but on an extremely small base, and core operations are still loss-making in Q2. The H1 profit is heavily dependent on non-operating other income, so shareholders should not read this as a sustainable turnaround. The NCLT-approved capital reduction is a positive structural step that will clean up the negative reserves, but the underlying business remains very small and the stock is likely to stay thinly traded and volatile.